KK
Kumari Kavita
About Kumari Kavita
Data last updated:
Kumari Kavita is a Director at Revanex Pharmaceuticals Private Limited (since 2022) and Director at Mansh Nephro Hospital Private Limited (since 2023). The companies operate in Chemicals and Healthcare. The largest current company by reported revenue is Revanex Pharmaceuticals Private Limited at ₹1.25 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revanex Pharmaceuticals Private Limited U24290WB2022PTC257023 | Director | 08 Sep 2022 | 2022 | ₹1.25 Cr (FY 2025) | Active |
| Mansh Nephro Hospital Private Limited U86100BR2023PTC064920 | Director | 31 Aug 2023 | 2023 | Active |
Board colleagues of Kumari Kavita
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babita Kumari | 09755265 | Revanex Pharmaceuticals Private Limited | Director |
| Debopriya Bhadra | 10753493 | Revanex Pharmaceuticals Private Limited | Director |
| Mita Mukhertee | 08450834 | Revanex Pharmaceuticals Private Limited | Director |
| Shashi Kumar | 08019841 | Mansh Nephro Hospital Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumari Kavita
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumari Kavita
Kumari Kavita currently holds 2 directorships: Revanex Pharmaceuticals Private Limited (Director, since 08 Sep 2022, revenue ₹1.25 Cr (FY 2025)); Mansh Nephro Hospital Private Limited (Director, since 31 Aug 2023).
Kumari Kavita was first appointed on 08 Sep 2022 as Director at Revanex Pharmaceuticals Private Limited. The most recent appointment on record is 31 Aug 2023 at Mansh Nephro Hospital Private Limited.
The current boards of Kumari Kavita's companies include Babita Kumari (Revanex Pharmaceuticals Private Limited), Debopriya Bhadra (Revanex Pharmaceuticals Private Limited), Mita Mukhertee (Revanex Pharmaceuticals Private Limited), Shashi Kumar (Mansh Nephro Hospital Private Limited).